Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Related Citations for PubMed (Select 24231879)

1.

Long-term drug treatment for obesity: a systematic and clinical review.

Yanovski SZ, Yanovski JA.

JAMA. 2014 Jan 1;311(1):74-86. doi: 10.1001/jama.2013.281361. Review.

2.

Formulary management of 2 new agents: lorcaserin and phentermine/topiramate for weight loss.

Kelly EM, Tungol AA, Wesolowicz LA.

J Manag Care Pharm. 2013 Oct;19(8):642-54. Review.

3.

Long-term pharmacotherapy for obesity and overweight.

Padwal R, Li SK, Lau DC.

Cochrane Database Syst Rev. 2004;(3):CD004094. Review.

PMID:
15266516
4.

Long-term pharmacotherapy for obesity and overweight.

Padwal R, Li SK, Lau DC.

Cochrane Database Syst Rev. 2003;(4):CD004094. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD004094.

PMID:
14584004
5.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
6.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of orlistat in the management of obesity.

O'Meara S, Riemsma R, Shirran L, Mather L, ter Riet G.

Health Technol Assess. 2001;5(18):1-81. Review.

7.

Pharmacotherapy for obesity.

Ioannides-Demos LL, Proietto J, McNeil JJ.

Drugs. 2005;65(10):1391-418. Review.

PMID:
15977970
8.

Meta-analysis: pharmacologic treatment of obesity.

Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR, Hilton L, Suttorp M, Solomon V, Shekelle PG, Morton SC.

Ann Intern Med. 2005 Apr 5;142(7):532-46.

PMID:
15809465
9.

New obesity agents: lorcaserin and phentermine/topiramate.

Fleming JW, McClendon KS, Riche DM.

Ann Pharmacother. 2013 Jul-Aug;47(7-8):1007-16. doi: 10.1345/aph.1R779. Epub 2013 Jun 25. Review.

PMID:
23800750
10.

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study.

Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, Schwiers M, Day WW, Bowden CH.

Am J Clin Nutr. 2012 Feb;95(2):297-308. doi: 10.3945/ajcn.111.024927. Epub 2011 Dec 7.

11.

Screening and Interventions for Childhood Overweight [Internet].

Whitlock EP, Williams SB, Gold R, Smith P, Shipman S.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Jul.

12.

The new weight-loss drugs, lorcaserin and phentermine-topiramate: slim pickings?

Woloshin S, Schwartz LM.

JAMA Intern Med. 2014 Apr;174(4):615-9. doi: 10.1001/jamainternmed.2013.14629.

PMID:
24515599
13.

Update on obesity pharmacotherapy.

Bray GA, Ryan DH.

Ann N Y Acad Sci. 2014 Apr;1311:1-13. doi: 10.1111/nyas.12328. Epub 2014 Mar 18. Review.

PMID:
24641701
14.

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.

Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW.

Lancet. 2011 Apr 16;377(9774):1341-52. doi: 10.1016/S0140-6736(11)60205-5. Epub 2011 Apr 8. Erratum in: Lancet. 2011 Apr 30;377(9776):1494.

PMID:
21481449
15.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

16.

What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.

Ara R, Blake L, Gray L, Hernández M, Crowther M, Dunkley A, Warren F, Jackson R, Rees A, Stevenson M, Abrams K, Cooper N, Davies M, Khunti K, Sutton A.

Health Technol Assess. 2012;16(5):iii-xiv, 1-195. doi: 10.3310/hta16050. Review.

17.
18.

A review of the metabolic effects of controlled-release Phentermine/Topiramate.

Kiortsis DN.

Hormones (Athens). 2013 Oct-Dec;12(4):507-16. Review.

19.

Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity.

Jordan J, Astrup A, Engeli S, Narkiewicz K, Day WW, Finer N.

J Hypertens. 2014 Jun;32(6):1178-88. doi: 10.1097/HJH.0000000000000145. Review.

20.

Bariatric surgery: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(1):1-148. Epub 2005 Jan 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk